ArticleHemaSphere2025
Response to luspatercept can be predicted and improves overall survival in the real-life treatment of LR-MDS.
Angela Consagra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled ittrialcites it